Original language | English |
---|---|
Pages (from-to) | 194-200 |
Journal | Prostate Cancer and Prostatic Diseases |
Volume | 8 |
Publication status | Published - 2005 |
Bicalutamide ('Casodex') 150 mg in addition to standard care in patients with nonmetastatic prostate cancer: updated results from a randomised double-blind phase III study (median follow-up 5.1 y) in the early prostate cancer programme
M. Wirth, C. Tyrrell, K. Delaere, M Sanchez-Chapado, J. Ramon, Michael Wallace, J. Hetherington, F. Pina, C. Heyns, T. Borchers, T. Morris, J. Armstrong
Research output: Contribution to journal › Article › peer-review
24
Citations
(Scopus)